| case report | Q2782326 |
| scholarly article | Q13442814 |
| P2093 | author name string | Shu-Yuan Xiao | |
| Victoria Gómez | |||
| P2860 | cites work | Pill esophagitis | Q33662819 |
| What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates | Q34787778 | ||
| Esophagitis associated with the use of alendronate | Q41102881 | ||
| Multinucleated epithelial giant cell changes in esophagitis: a clinicopathologic study of 14 cases | Q42449084 | ||
| Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. | Q48527134 | ||
| Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. | Q53803388 | ||
| From the Food and Drug Administration | Q71060209 | ||
| Alendronate-associated esophageal injury: pathologic and endoscopic features | Q73320235 | ||
| Alendronate-associated esophagitis: endoscopic and pathologic features | Q74731685 | ||
| Esophageal irritation due to alendronate sodium tablets: possible mechanisms | Q77349024 | ||
| P433 | issue | 2 | |
| P921 | main subject | esophagitis | Q298230 |
| P304 | page(s) | 200-203 | |
| P577 | publication date | 2008-06-20 | |
| P1433 | published in | International Journal of Clinical and Experimental Pathology | Q6051341 |
| P1476 | title | Alendronate-induced esophagitis in an elderly woman | |
| P478 | volume | 2 |
Search more.